








DEFINITION
OCCURRENCE & TISSUE
DISTRIBUTION
BIOMEDICAL IMPORTANCE
METABOLIC STEPS
REGULATION
CLINICAL IMPORTANCE
REFERENCES
ACKNOWLEDGEMENTS
IT IS AN ALTERNATIVE
PATHWAY FOR
OXIDATION OF
GLUCOSE.
IN CYTOPLASM
LIVER

ADIPOSE TISSUE
Major Function is to produce

D-Glucuronic acid which is required
for:
Detoxification of foreign chemicals.
Synthesis of MPS.
There is no energy production.
GLUCOSE
Glucokinase ATP ADP
Glucose 6-phospate
PhosphoglucoMutase
Glucose 1-phosphate
UDP-Glu-pyrophosPhorylase

UTP PPi

UDP-Glucose
UDP-Gludehydrogenase

2NAD+ 2NADH + H+

UDP-Glucoronate
phosphorylation
D-Glucuronic acid 1-P
Glucuronidase

H2O UDP

D-Glucoronic acid
LGDH

L-Gulonic acid
L-Gulonic acid
beta-HD

L- Gulonolactone

3-Ketogulonic
Acid

oxidase
L-Ascorbic acid

beta-keto L-gulonate decarboxylase

L-Xylulose
Xylulose reductase

Xylitol
NAD+ NADH + H+
D-Xylulose
Xylulose kinase

ATP ADP

Xylulose 5-phosphate

HMP Shunt
 Administration of drugs i.e

Chlorobutanol &
Barbital significantly increases the uronic
acid pathway.
 Certain drugs are also found to enhance

the synthesis of Ascorbic acid.
o ESSENTIAL PENTOSURIA:

It is an Autosomal recessive disorder.

Metabolic defect:Deficiency of

Xylitol Reductase





BIOCHEMISTRY BY THOMAS. M.DEVLIN
,Edition no.7Pg.655 &656
HARPER’S ILLUSTRATED BIOCHEMISTRY
EDITION NO.29,Pg.201 &202
MED. BIOCHEMISTRY BY MN.CHATTERJEA
EDITION NO.8, Pg.362 & 363
BIOCHEMISTRY BY U.SATYANARAYANA
EDITION NO.3, Pg.276
Uronic acid pathway

Uronic acid pathway